Oral upadacitinib may be a promising treatment option for patients with atopic dermatitis-type chronic hand eczema that is ...

GAAP revenue for Q2 2025 rose to $217.1 million, up 11% from the prior year and beating expectations. Management reduced full-year 2025 revenue and diluted net income per share guidance due to a ...

Hims & Hers Health stock fell as much as 5% early Tuesday after the company reported revenue late Monday that fell shy of Wall Street forecasts while maintaining its full-year for ...

The products were distributed to commercial and retail distributors in five states; Texas, Minnesota, Oklahoma, Arkansas and ...

The products were distributed to commercial and retail distributors in five states; Texas, Minnesota, Oklahoma, Arkansas and ...

I’ve always believed that once your eyesight starts to fade, there’s not much you can do—besides stronger glasses and ...

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...

Hims & Hers delivered strong Q2 growth, driven by compounded GLP-1 offerings, but faces uncertainty as regulatory and supply ...

In an open letter, 22 experts who designed and ran Replimmune’s Phase III IGNYTE trial answered the FDA’s issues, as outlined ...

Lack of formal diagnostics and research data makes it difficult for long COVID sufferers to get workers’ compensation claims ...

The Florida Department of Health warns of 21 illnesses linked to raw milk consumption, including severe cases, urging caution ...

Unlike smoke shops or gas stations advertising kratom-derived concentrates, these coffee shop-style retailers serve drinks ...